atenolol has been researched along with hydralazine in 31 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 14 (45.16) | 18.7374 |
| 1990's | 4 (12.90) | 18.2507 |
| 2000's | 10 (32.26) | 29.6817 |
| 2010's | 3 (9.68) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Wilcox, RG | 1 |
| Brunner, HR; Hayoz, D; Meister, JJ; Perret, F; Tardy, Y; Waeber, B | 1 |
| Armitage, JM; Griffith, BP; Hardesty, RL; Kormos, RL; Lee, A; Schechter, D; Ziady, GM | 1 |
| Coutard, M; Osborne-Pellegrin, M | 1 |
| Barrios, SJ; Casasnovas, JA; de la Fuente, V; Escosa, L; Ferreira, IJ; Marcos, JM; Navarro, A; Pardell, H | 1 |
| Leenen, FH; Reeves, RA | 1 |
| Benedetti, TJ; Carlson, KL; Easterling, TR; Schmucker, BC | 1 |
| Buchholz, RA; Hubbard, JW; Keeton, TK; Nathan, MA; Reed, K | 1 |
| Leenen, FH; Reeves, RA; Smith, DL | 1 |
| Bailey, BP; Duggin, GG; Fletcher, PJ; Hall, B; Horvath, JS; Tiller, D | 1 |
| Parnell, L; Ramsay, LE; Waller, PC | 1 |
| Hannan, WJ; Muir, AL; Wathen, CG | 1 |
| Ooshima, A; Tarazi, RC; Yamori, Y | 1 |
| Latham, L; Lorimer, AR; McAreavey, D; McLaren, AD; Ramsey, LE; Reid, JL; Robertson, JI; Robertson, MP; Weir, RJ | 1 |
| Ambrosioni, E; Caldari, R; Costa, FV; Malini, PL; Marata, AM; Parini, J; Strocchi, E | 1 |
| Bolt, GR; Saxena, PR | 1 |
| Jones, JV; Steiner, JM | 1 |
| Elghozi, JL; Girolami, JP; Grichois, ML; Ponchon, P | 1 |
| Bednar, MM; Ellenberger, C; Gross, CE; Howard, DB; Russell, SR | 1 |
| Ferrario, CM; Gallagher, PE; Geary, RL; Igase, M; Strawn, WB | 1 |
| Baudrie, V; Elghozi, JL; Laude, D | 2 |
| Christian, R; Colon, PJ; Cushman, WC; Einhorn, PT; Ford, CE; Goff, DC; Henriquez, MA; Margolis, KL; Piller, LB; Vidt, DG; Wong, ND; Wright, JT | 1 |
| Boor, P; Cohen, CD; Denecke, B; Eitner, F; Floege, J; Gan, L; Konieczny, A; Kunter, U; Neusser, MA; Ostendorf, T; Scholl, T; van Roeyen, CR; Villa, L | 1 |
1 review(s) available for atenolol and hydralazine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
11 trial(s) available for atenolol and hydralazine
| Article | Year |
|---|---|
Combination hypotensive therapy with atenolol, bendrofluazide and hydrallazine.
Topics: Angiotensin II; Atenolol; Bendroflumethiazide; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydralazine; Hypertension; Male; Propanolamines; Renin | 1977 |
Non-invasive determination of arterial diameter and distensibility by echo-tracking techniques in hypertension.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Animals; Arteries; Atenolol; Blood Pressure; Captopril; Compliance; Dipeptides; Double-Blind Method; Humans; Hydralazine; Hypertension; Lisinopril; Nitrendipine; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Ultrasonography | 1992 |
[Multicenter study of atenolol, combined with hydralazine and bendroflumethiazide in the treatment of essential, mild, and severe, arterial hypertension].
Topics: Adult; Aged; Atenolol; Bendroflumethiazide; Drug Therapy, Combination; Female; Humans; Hydralazine; Hypertension; Male; Middle Aged; Severity of Illness Index | 1989 |
Beta-receptor-mediated increase in venous return in humans.
Topics: Adult; Atenolol; Clinical Trials as Topic; Double-Blind Method; Echocardiography; Epinephrine; Female; Heart; Heart Ventricles; Humans; Hydralazine; Isoproterenol; Male; Propranolol; Random Allocation; Receptors, Adrenergic, beta; Terbutaline; Veins; Ventricular Function | 1987 |
Hemodynamic interaction of nonselective vs. beta-1-selective beta-blockade with hydralazine in normal humans.
Topics: Adolescent; Adult; Atenolol; Blood Pressure; Catecholamines; Double-Blind Method; Female; Heart Rate; Hemodynamics; Humans; Hydralazine; Male; Myocardial Contraction; Propranolol; Random Allocation; Renin | 1987 |
Verapamil in essential hypertension: a comparison with atenolol plus hydralazine.
Topics: Adult; Aged; Atenolol; Blood Pressure; Double-Blind Method; Drug Therapy, Combination; Echocardiography; Electrocardiography; Female; Heart Rate; Humans; Hydralazine; Hypertension; Male; Middle Aged; Random Allocation; Verapamil | 1987 |
Comparison of nifedipine, prazosin and hydralazine added to treatment of hypertensive patients uncontrolled by thiazide diuretic plus beta-blocker.
Topics: Adult; Aged; Atenolol; Bendroflumethiazide; Blood Pressure; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Hydralazine; Hypertension; Male; Middle Aged; Nifedipine; Prazosin; Random Allocation | 1987 |
"Third drug" trial: comparative study of antihypertensive agents added to treatment when blood pressure remains uncontrolled by a beta blocker plus thiazide diuretic.
Topics: Adolescent; Adult; Aged; Antihypertensive Agents; Atenolol; Bendroflumethiazide; Blood Pressure; Clinical Trials as Topic; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Hydralazine; Hypertension; Labetalol; Male; Methyldopa; Middle Aged; Minoxidil; Prazosin | 1984 |
Comparison of the antihypertensive activity of cadralazine (ISF 2469) and dihydralazine during chronic treatment.
Topics: Adult; Antihypertensive Agents; Atenolol; Blood Pressure; Dihydralazine; Female; Headache; Heart Rate; Humans; Hydralazine; Hypertension; Male; Middle Aged; Nausea; Pyridazines; Random Allocation; Water-Electrolyte Imbalance | 1983 |
Double-blind cross-over comparison of hydralazine and prazosin in hypertensive subjects on a beta-adrenoceptor blocking agent (atenolol).
Topics: Atenolol; Double-Blind Method; Drug Therapy, Combination; Humans; Hydralazine; Hypertension; Prazosin; Propanolamines; Quinazolines | 1980 |
Blood pressure control in Hispanics in the antihypertensive and lipid-lowering treatment to prevent heart attack trial.
Topics: Aged; Amlodipine; Antihypertensive Agents; Atenolol; Black People; Blood Pressure; Canada; Chlorthalidone; Clonidine; Double-Blind Method; Doxazosin; Female; Heart Diseases; Hispanic or Latino; Humans; Hydralazine; Hypertension; Hypolipidemic Agents; Lisinopril; Male; Middle Aged; Puerto Rico; Reserpine; Treatment Outcome; United States; United States Virgin Islands; White People | 2007 |
19 other study(ies) available for atenolol and hydralazine
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Efficacy of antihypertensive medication in orthotopic heart transplant recipients and its effect on renal function.
Topics: Adult; Antihypertensive Agents; Atenolol; Blood Pressure; Blood Urea Nitrogen; Creatinine; Enalapril; Female; Heart Transplantation; Humans; Hydralazine; Kidney; Male; Middle Aged; Retrospective Studies | 1992 |
Rupture of the internal elastic lamina and vascular fragility in stroke-prone spontaneously hypertensive rats.
Topics: Animals; Arteries; Atenolol; Blood Pressure; Capillary Fragility; Captopril; Cerebrovascular Disorders; Hydralazine; Muscle, Smooth, Vascular; Rats; Rats, Inbred SHR; Rats, Mutant Strains; Renal Artery; Rupture, Spontaneous; Vascular Diseases | 1991 |
Antihypertensive therapy in pregnancy directed by noninvasive hemodynamic monitoring.
Topics: Atenolol; Cardiac Output; Female; Hemodynamics; Humans; Hydralazine; Hypertension; Pregnancy; Pregnancy Complications, Cardiovascular; Vascular Resistance | 1989 |
Changes in plasma catecholamines and plasma renin activity during hypotension in conscious rats with lesions of the nucleus tractus solitarii.
Topics: Animals; Atenolol; Blood Pressure; Cardiovascular System; Consciousness; Denervation; Electric Stimulation; Hydralazine; Hypotension; Kidney; Male; Medulla Oblongata; Neurosecretory Systems; Norepinephrine; Pressoreceptors; Rats; Rats, Inbred Strains; Reflex; Renin | 1988 |
Effects of felodipine on resistance and capacitance vessels in patients with essential hypertension.
Topics: Adult; Aged; Antihypertensive Agents; Atenolol; Blood Pressure; Blood Vessels; Electrocardiography; Felodipine; Heart Rate; Humans; Hydralazine; Hypertension; Middle Aged; Nifedipine; Nitroglycerin; Stroke Volume; Vascular Resistance | 1985 |
Effect of beta-receptor-blocking agents on cardiovascular structural changes in spontaneous and noradrenaline-induced hypertension in rats.
Topics: Animals; Aorta; Atenolol; Heart Ventricles; Hydralazine; Hypertension; Male; Norepinephrine; Organ Size; Phentolamine; Propanolamines; Propranolol; Protein Biosynthesis; Rats; RNA | 1980 |
Interaction of atenolol with the systemic and regional hemodynamic effects of hydralazine in conscious renal hypertensive rabbits.
Topics: Animals; Atenolol; Blood Gas Analysis; Drug Interactions; Electric Conductivity; Heart Rate; Hemodynamics; Hydralazine; Hypertension, Renal; Male; Rabbits; Regional Blood Flow; Stroke Volume; Vascular Resistance | 1984 |
Effects of bradykinin on short-term variability in blood pressure and heart rate in rats: a spectral study.
Topics: Adrenergic beta-Antagonists; Analysis of Variance; Animals; Atenolol; Blood Pressure; Blood Pressure Determination; Bradykinin; Dose-Response Relationship, Drug; Drug Interactions; Heart Rate; Hydralazine; Male; Rats; Rats, Wistar; Respiration; Therapeutic Equivalency; Vasodilation; Vasodilator Agents | 1995 |
The effect of vasodilators on aspirin-induced antagonism of t-PA thrombolysis.
Topics: Animals; Antihypertensive Agents; Aspirin; Atenolol; Brain Ischemia; Cerebrovascular Circulation; Drug Interactions; Drug Therapy, Combination; Female; Fibrinolytic Agents; Hydralazine; Male; Nitric Oxide; Nitric Oxide Donors; Prostaglandins, Synthetic; Rabbits; Thromboembolism; Thrombolytic Therapy; Tissue Plasminogen Activator; Treatment Outcome; Vasodilator Agents | 2001 |
Angiotensin II AT1 receptors regulate ACE2 and angiotensin-(1-7) expression in the aorta of spontaneously hypertensive rats.
Topics: Adrenergic beta-Antagonists; Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Animals; Aorta, Thoracic; Atenolol; Carboxypeptidases; Carotid Arteries; Gene Expression Regulation, Enzymologic; Hydralazine; Hypertension; Imidazoles; Male; Olmesartan Medoxomil; Peptide Fragments; Peptidyl-Dipeptidase A; Rats; Rats, Inbred SHR; Receptor, Angiotensin, Type 1; RNA, Messenger; Tetrazoles; Vasodilator Agents | 2005 |
Optimal frequency ranges for extracting information on cardiovascular autonomic control from the blood pressure and pulse interval spectrograms in mice.
Topics: Animals; Atenolol; Atropine; Autonomic Nervous System; Blood Pressure; Cardiovascular Physiological Phenomena; Heart Rate; Hydralazine; Male; Mice; Mice, Inbred C57BL; Parasympathomimetics; Prazosin; Signal Processing, Computer-Assisted; Sympatholytics; Telemetry; Vasodilation; Vasodilator Agents | 2007 |
Applicability of recent methods used to estimate spontaneous baroreflex sensitivity to resting mice.
Topics: Algorithms; Animals; Antihypertensive Agents; Atenolol; Atropine; Baroreflex; Blood Pressure; Fourier Analysis; Hydralazine; Male; Mice; Mice, Inbred C57BL; Parasympatholytics; Prazosin; Pulse; Rest | 2008 |
Late angiotensin II receptor blockade in progressive rat mesangioproliferative glomerulonephritis: new insights into mechanisms.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Atenolol; Benzimidazoles; Benzoates; Blood Pressure; Cell Dedifferentiation; Cell Line; Chemokine CCL20; Cytoprotection; Disease Models, Animal; Fibrosis; Gene Expression Profiling; Gene Expression Regulation; Glomerular Mesangium; Glomerulonephritis, Membranoproliferative; Humans; Hydralazine; Hydrochlorothiazide; Hypertension; Inflammation; Isoantibodies; Macrophages; Male; Mice; Nephrectomy; Podocytes; Proteinuria; Rats; Rats, Wistar; Receptors, CCR6; Receptors, Platelet-Derived Growth Factor; RNA Interference; RNA, Messenger; Telmisartan; Time Factors; Transfection | 2013 |